![Brian Schwartz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Schwartz
No open positions remaining
Profile
Brian D.
Schwartz formerly worked at Infinity Pharmaceuticals, Inc., as Director from 2021 to 2023, Mereo BioPharma Group Plc, as Director from 2020 to 2022, LifeSci Acquisition Corp., as Independent Director in 2020, Enlivex Therapeutics Ltd., as Director from 2020 to 2025, ArQule, Inc., as Chief Medical Officer, Head-Research & Development from 2008 to 2020, Alaunos Therapeutics, Inc., as Chief Medical Officer, Intensity Therapeutics, Inc., as Executive VP-Clinical Development, and Cyclacel Pharmaceuticals, Inc., as Chief Medical Officer in 2025.
Dr. Schwartz received his doctorate degree in 1985 from the University of Pretoria.
Former positions of Brian Schwartz
| Companies | Position | End |
|---|---|---|
| ENLIVEX LTD. | Director/Board Member | 04/01/2025 |
| BIO GREEN MED SOLUTION, INC. | Chief Tech/Sci/R&D Officer | 04/01/2025 |
| INTENSITY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 04/01/2025 |
| INFINITY PHARMACEUTICALS, INC. | Director/Board Member | 24/07/2023 |
| MEREO BIOPHARMA GROUP PLC | Director/Board Member | 10/11/2022 |
Training of Brian Schwartz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Intensity Therapeutics, Inc.
 Intensity Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops and markets proprietary intratumoral immunotherapy products for cancer treatment | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of Pretoria
 University of Pretoria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
LifeSci Acquisition Corp.
 LifeSci Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Brian Schwartz
